The Sweet Pee model for Sglt2 mutation.
Ly JP, Onay T, Sison K, Sivaskandarajah G, Sabbisetti V, Li L, Bonventre JV, Flenniken A, Paragas N, Barasch JM, Adamson SL, Osborne L, Rossant J, Schnermann J, Quaggin SE.
Ly JP, et al. Among authors: rossant j.
J Am Soc Nephrol. 2011 Jan;22(1):113-23. doi: 10.1681/ASN.2010080888.
J Am Soc Nephrol. 2011.
PMID: 21209254
Free PMC article.
An animal model with sglt2 dysfunction could provide information regarding the potential long-term safety and efficacy of SGLT2 inhibitors, which are currently under clinical investigation. ...After induction of diabetes, Sweet Pee mice had better overall glycemic control …
An animal model with sglt2 dysfunction could provide information regarding the potential long-term safety and efficacy of SGLT2 inhib …